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Prevents the Emergence of Anxiety Behavior,
Dysregulated Stress-Induced Immediate Early Gene
Responses, and Specific Transcriptional Changes that
Arise Following Early Life Stress
Madhurima Benekareddy, Krishna C. Vadodaria, Amrita R. Nair, and Vidita A. Vaidya
Background: Early life adverse experience contributes to an enhanced vulnerability for adult psychopathology. Recent evidence indicates
that serotonin type 2 (5-HT2) receptor function, implicated in the pathophysiology ofmood and anxiety disorders, is significantly enhanced
in the maternal separation model of early life stress. We examined whether postnatal 5-HT2 receptor blockade would prevent the
onsequences of maternal separation on anxiety behavior and dysregulated gene expression.
ethods: Control and maternally separated litters received treatment with the 5-HT2 receptor antagonist, ketanserin, or vehicle during
ostnatal life andwereexamined for effects onadult anxietybehavior, adult stress-induced immediate earlygeneexpression responses, and
ranscriptional changes within the prefrontal cortex during postnatal life and in adulthood.
esults: Treatment with ketanserin during postnatal life blocked the long-lasting effects of maternal separation on anxiety behavior in
he open field test and the elevated plus maze. Further, the dysregulated adult stress-induced expression pattern of the immediate early
ene, Arc, observed in maternally separated animals was also prevented by postnatal ketanserin treatment. Ketanserin treatment normal-
zed the alterations in the expression of specific genes in the prefrontal cortex of maternally separated animals, including changes in
erotonin type 2A receptormessenger RNA expression during postnatal life and in genes associatedwith G-protein signaling in adulthood.
onclusions: Postnatal treatment with the 5-HT2 receptor antagonist, ketanserin, blocked specific consequences of maternal separation,
ncluding anxiety behavior and dysregulated gene expression in the prefrontal cortex. Our results suggest that enhanced 5-HT2 receptor
function may contribute to the emergence of anxiety behavior and perturbed stress responses following early life stress.
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A history of early life adverse experience is a major risk factorfor the development of anxiety and depressive disorders(1–3). Rodent models of early life stress, such as maternal
eparation (MS), exhibit endophenotypes of these affective disor-
ers (4–6). MS, which involves daily 3-hour long separations of the
itter from their dam from postnatal days 2 to 14, results in en-
anced adult anxiety behavior (7–9). Further, MS animals exhibit
erturbed neuroendocrine stress responses in adulthood (7,10,11),
hich could serve to disrupt homeostasis and exacerbate the risk
or psychopathology. The consequences ofMS have been reported
o endure across the life span, indicating the relatively persistent
ature of the changes in emotionality.
Serotonergic neurocircuitry is known to be involved in the de-
elopment of anxiety (12–14). Serotonin type 2 (5-HT2) receptors
have been implicated as possible targets to modulate anxiety be-
havior. Serotonin type 2A (5-HT2A) and serotonin type 2C (5-HT2C)
eceptor knockouts are reported to exhibit reduced anxiety re-
ponses, suggesting a role for the 5-HT2 receptors in establishing a
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doi:10.1016/j.biopsych.2011.08.005aseline anxiety state (15,16). However, it remains unknown
hether 5-HT2 receptors contribute to the enhanced anxiety and
erturbed stress responses that arise following early life stress ex-
osure. Recent evidence indicates that MS animals exhibit signifi-
antly enhanced 5-HT2 receptor function in the prefrontal cortex
PFC) and increased 5-HT2 receptor driven behavioral responses
17). We hypothesized that pharmacological blockade of the 5-HT2
eceptor duringMSmay prevent several of the long-term sequelae
f this early life stress exposure, including the development of
nhanced anxiety. Here, we show that postnatal 5-HT2 receptor
lockade prevents the emergence of specific consequences of MS,
amely enhanced anxiety behavior observed in adulthood, dys-
egulated immediate early gene (IEG) responses to adult-onset
tress, and specific transcriptional changes in the PFCofMS animals
nbothpostnatal life andadulthood.Our results implicate the5-HT2
eceptor in the development of altered emotionality that arises
ollowing early life adverse experience.
ethods andMaterials
nimal Treatment Paradigms
Sprague-Dawley rats bred in the Tata Institute of Fundamental
esearch animal facility were group housed and maintained on a
2-hour light-dark cycle with access to food and water ad libitum.
nimal procedures were carried out in accordance with the Na-
ional Institutes of Health Guide for the Care and Use of Laboratory
nimals and approved by the Tata Institute of Fundamental Re-
earch Institutional Animal Ethics Committee.
Pregnant primiparous female rats delivered litters and were as-
igned randomly to control or MS groups. MS involved separation
f the pups from the dam for 3 hours daily frompostnatal days (P) 2
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M. Benekareddy et al. BIOL PSYCHIATRY 2011;70:1024–1032 1025to 14, as described previously (18). For experiments involving post-
natal administration of the 5-HT2 receptor antagonist, ketanserin
artrate (5 mg/kg; Sigma, Taufkirchen, Germany), control and MS
itters were orally administered vehicle (5% glucose) or ketanserin
sing a feeding needle before the onset of each separation fromP2
oP14. Thedoseof ketanserin selectedwasbasedonprior literature
19,20).
ehavioral Experiments: Open Field and Elevated Plus Maze
To address the consequences of ketanserin treatment during
S on adult anxiety behavior in the open field (21) and elevated
lusmaze (22), the experimental designhad four treatmentgroups:
ontrol with vehicle, control with ketanserin (Ket), MS with vehicle
MS), and MS with ketanserin (MS  Ket) (n  4–7 per group).
nimals were placed in the open field (100 cm 100 cm 70 cm)
n one corner facing the center and allowed to explore the arena for
5minutes. The elevated plusmaze had a height of 50 cmwith two
pen and two closed arms (50 10 cm). Animalswere placed in the
enter of the maze, facing an open arm, and allowed to explore for
0 minutes. The behavior was recorded using a charge-coupled
evice camera and analyzed using the automated Ethovision track-
ng system (Noldus, Wageningen, The Netherlands).
dult-Onset Stress Experiments
To examine whether MS altered the pattern of IEG responses to
dult-onset stress, control andMSanimals inadulthood (P90) received
cute immobilization stress (AIS) (2 hours) or chronic immobilization
tress (CIS) (2 hours daily for 10 days). Immobilization stress involved
lacing the animals in rodent restrainer cones (Stoelting Company,
Figure 1. Postnatal treatment with the serotonin type 2 receptor antagonis
aternal separation in the openfield test. Shown is a schematic for the treatm
were fed either vehicle (Veh) or Ket daily from postnatal days (P) 2 to 14 and
are representative tracks of the behavior of adult Ctl andMS animals (fed eith
decrease in both number of entries (C) and the percent path length (D) tra
blockade with Ket prevented the enhanced anxiety observed in MS animals
of the open field. Postnatal Ket treatment to control animals did not alter a
expressed as themean SEM number of entries into or percent path length
tl, $p .05 as compared with MS; analysis of variance and Bonferroni postood Dale, Illinois). Treatment groups were as follows: 1) AIS experi- (ent: control, AIS, MS, MS  AIS (n  3–5 per group); and 2) CIS
xperiment: control, CIS, MS, MS CIS (n 3–5 per group). We next
ddressedwhether ketanserin treatment duringMSwould normalize
heperturbed IEG response inMSanimals subjected toCIS. Treatment
roups were as follows: vehicle-treated cohort: control  vehicle,
S vehicle, control vehicleCIS,MS vehicleCIS; and ketan-
erin-treated cohort: control ketanserin,MS ketanserin, control
etanserinCIS,MSketanserinCIS (n5–10pergroup).Animals
ere sacrificed by rapid decapitation and brains were dissected and
tored at70°C until further processing.
ene Expression Analysis: In Situ Hybridization and
uantitative Polymerase Chain Reaction
In situ hybridization was performed to examine expression of
he IEG and activity-regulated cytoskeletal-associated protein
Arc) in the PFC following AIS and CIS in control and MS animals
nd to examine whether ketanserin treatment altered the adult
tress-induced IEG response (18). In situ hybridization was also
arried out to assess 5-HT2A and 5-HT2C receptor expression in
he PFC at P10 and P14 in control, MS, and MS Ket groups (n
–6 per group). In brief, cryostat-cut sections (14 m) were
haw-mounted onto ribonuclease free Probe-on plus slides
Electron Microscopy Services, Columbia, Maryland) before fixa-
ion. 35S-UTP labeled (Amersham, Buckinghamshire, United
ingdom) riboprobes against Arc were generated from a tran-
cription-competent plasmid kindly provided by Dr. O. Steward
Johns Hopkins University) and against 5-HT2A and 5-HT2C recep-
ors from templates generated by polymerase chain reaction
nserin (Ket), blocks the enhanced adult anxiety responses associated with
paradigms (A). Pups fromcontrol (Ctl) andmaternal separation (MS) groups
behavior was assessed in the open field test in adulthood (P90). (B) Shown
hor Ket) in an open field arena.Maternal separation resulted in a significant
in the center of the open field arena. Postnatal serotonin type 2 receptor
easured by number of entries (C) and percent path length (D) in the center
behavior as compared with Veh-administered Ctl animals. The results are
e center of the open field (n 4–7 per group). (*p .05 as compared with
est).t, keta
ent
their
er Ve
versed
, as m
nxiety
in thPCR) amplification from rat complementary DNA with specific
www.sobp.org/journal
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1026 BIOL PSYCHIATRY 2011;70:1024–1032 M. Benekareddy et al.primers containing T3 and T7 template sequences (5-HT2A for-
ward: AATTAACCCTCACTAAAGGGCTGGTCATCATGGCAGTGTC;
reverse: TAATACGACTCACTATAGGGTCTGAGGGAGGAAGCTGAAG;
5-HT2C forward AATTAACCCTCACTAAAGGGTAATCGGCCTATTG-
GTTTGG; reverse: TAATACGACTCACTATAGGGTCACGAACACTTT-
GCTTTCG). Sections were incubated with the 35S-UTP-labeled ribo-
probe (1  106cpm/slide) for 20 hours at 60°C, followed by
ribonuclease A (RNase A, 20 g/mL; USB Corporation, Cleveland,
Ohio) treatment and stringent washes. Slides were dried and ex-
posed to Hyperfilm -max (Amersham) for 5 days. Messenger RNA
(mRNA) levels were quantitated using the Macintosh-based Scion
Image Software (Scion, Frederick, Maryland) and 14C standards for
calibration. For Arc mRNA levels, equivalent areas of the PFC were
outlined for optical density measurements. For 5-HT2A and 5-HT2C
mRNA expression within the PFC, levels were ascertained in the
infralimbic (IL), prelimbic (PL), and cingulate cortex (CC). Optical
density values obtained from both sides of 3 to 4 sections for each
animal (6–8measurements)were averaged toobtain ameanvalue.
To address whether postnatal ketanserin treatment during MS
altered gene expression of specific genes (17) in the PFC (Prkcb1,
Ppp3ca, Plek, Plcd4, Nlgn1, Grin2d) in adulthood, we performed
quantitative polymerase chain reaction on animals belonging to
the following groups: control with vehicle, MS, Ket, MS Ket (n
5–10 per group). RNA was extracted using the TRI reagent (Sigma)
and reverse transcribed followed by quantitative polymerase chain
reaction with Taqman probes (Applied Biosystems, Carlsbad, Cali-
fornia). The data were normalized to the average of four house-
keeping genes (18s rRNA, Actb, Gapdh, andHprt) and changes in the
mRNA levels were quantified using the 		Ct method (23,24). See
Figure 2. Postnatal treatment with the serotonin type 2 receptor antago
nimals in the elevated plus maze. Shown is the experimental parad
antagonist ketanserin (Ket) or vehicle (Veh) to rat pups from control (Ctl)
of the time spent in the open (O) and closed arms (CD) of the elevated plu
ath length in the open arm (D) revealed a significant decrease in the MS
S, asmeasured by percent path length (D) in the open arms of the eleva
ehavior as compared with vehicle-administered Ctl animals. The results
n the open arm of the elevated plus maze (n 4–7 per group). (*p .05
Bonferroni post hoc test). P, postnatal day.Table S1 in Supplement 1 for a list of primers used. c
www.sobp.org/journaltatistical Analysis
Statistical analysis was performed using the software Prism
Graphpad, La Jolla, California). Experiments with four groups were
ubjected to a two-way analysis of variance (ANOVA), followed by a
onferroni post hoc test. Experiments with three groups were sub-
ected to a one-way ANOVA, followed by a Bonferroni post hoc test.
ata that showed a nonparametric distribution were subjected to
he Kruskal-Wallis test followed by a Dunn’s post hoc test. Signifi-
ance was determined at p .05.
esults
ostnatal Ketanserin Treatment Blocks the Emergence of
dult Anxiety Behavior in Maternally Separated Animals
We have previously shown that MS is associated with signifi-
antly enhanced 5-HT2 receptor function (17). Here, we sought to
ddress whether postnatal treatment with the 5-HT2 receptor an-
agonist ketanserin prevents the anxiogenic effects of MS in adult-
ood observed in the open field and elevated plus maze tests.
Postnatal ketanserin treatment blocked the enhanced anxiety
esponses observed with MS in the open field (Figure 1A–D). Two-
ay ANOVA analysis revealed a significant MS Ket interaction for
he number of entries [F (1,19)  9.27, p  .007] and the percent
ath length in the center of the open field [F (1,19) 5.48, p .03].
hile MS animals exhibited increased anxiety behavior with a sig-
ificant decrease in both number of entries (Figure 1C) and percent
ath length (Figure 1D) in the center of the open field, theMS Ket
roup showed a blockade of these anxiety responses and were
locks the increased anxiety behavior observed in maternally separated
A) involving postnatal treatment with the serotonin type 2 receptor
ternal separation (MS) groups. (B) Shown are representative heat maps
e. Analysis of the percent entries into the open arms (C) and the percent
p. Postnatal treatment with Ket blocked the anxiety behavior following
lusmaze. Postnatal Ket treatment to control animals did not alter anxiety
xpressed as the mean SEM percent entries into or percent path length
pared with control, $p .05 compared with MS; analysis of variance andnist b
igm (
or ma
smaz
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M. Benekareddy et al. BIOL PSYCHIATRY 2011;70:1024–1032 1027the open field arenawas similar across all treatment groups (Figure
S1A in Supplement 1).
Postnatal ketanserin treatment also blocked specific anxiety re-
sponses of MS animals in the elevated plus maze (Figure 2A–D). Two-
wayANOVAanalysis revealed a significantMSKet interaction in the
percent path length traversed in the open arms [F (1,19) 5.21, p
.03].MS animals showed significant increases in anxiety behaviorwith
adecrease inpercentpath length in theopenarmsof themaze (Figure
2B,D).ThismeasureofanxietywasblockedinMSanimals that received
postnatal ketanserin treatment and was comparable with the control
group. MS animals also showed a significant decrease in percent en-
tries into the open arms (Figure 2B, C). However, for this measure,
two-wayANOVAanalysis didnot reveal a significantMSKet interac-
tion. The total distance traveled in the elevated plusmaze was similar
across all treatment groups (Figure S1B in Supplement 1). Ketanserin
treatment incontrol animalsdidnotalterbaselineanxietybehavioron
either the open field or the elevated plusmaze.
Maternal Separation Leads to a Dysregulated Expression of
the Immediate Early Gene, Arc, in Response to Adult
Immobilization Stress
Exposure to diverse stressors, including immobilization stress, is
reported to evoke enhanced expression of the 5-HT2 receptor reg-
ulated IEG, Arc, in the PFC (25,26). Given the perturbed prefrontal
5-HT2 receptor function inMSanimals,wehypothesized that stress-
voked patterns of ArcmRNA expression may be aberrant in these
nimals.
Acute immobilization stress exposure resulted in a robust induc-
ion of prefrontal ArcmRNA in both control andMS animals (Figure
A, B). Two-way ANOVA analysis revealed no significant MS  AIS
Figure 3. A life history of maternal separation alters the pattern of regula
to adult-onset chronic immobilization stress. Shown is a schematic for th
adulthood to either (A) sham or AIS or (C) sham or CIS as described in
analysis was utilized to assess the levels of Arcmessenger RNA (mRNA) in
levels in the prefrontal cortex from Ctl, MS, AIS, and MS AIS groups (B)
evoked a similar pattern of Arc mRNA regulation in both Ctl and MS an
showed a habituation of the ArcmRNA regulation by stress (D). In striking
evels following adult-onset CIS exposure (D). Results are expressed as
ompared with Ctl, $p .01 significantly different from MS, 
p .05 sign
bbreviations as in Figures 1 and 2.nteraction. MS did not significantly regulate baseline Arc mRNA sxpression in the PFC. This indicates that theAIS-inducedpattern of
rc mRNA regulation in the PFC does not differ between animals
ith a normal or adverse early life history. Repeated exposure to a
omotypic stressor, including immobilization stress, has been re-
orted to result in the habituation of cortical Arc mRNA induction
27). We asked whether MS animals exhibit a similar pattern of
abituation in prefrontal ArcmRNA induction in response to CIS in
dulthood (Figure 3C). Strikingly,MS animals failed to showahabit-
ation of Arc mRNA upregulation in the PFC despite repeated ex-
osure to immobilization stress once daily for 10 days in contrast to
ontrol animals (Figure 3D). Two-way ANOVA analysis revealed a
ignificantMS CIS interaction for ArcmRNA regulation in the PFC
F (1,14) 15.02; p .0017]. These results demonstrate that a his-
ory ofMS results in a dysregulated IEG pattern in the PFC following
hronic, but not acute, exposure to immobilization stress.
ostnatal Ketanserin Treatment Normalizes the Dysregulated
attern of ArcmRNA Regulation Observed Following Chronic
tress in Maternally Separated Animals
We next sought to examine whether postnatal ketanserin treat-
ent was capable of normalizing the dysregulated pattern of pre-
rontal Arc mRNA expression evoked by CIS in MS animals (Figure
A). MS animals administered vehicle in early life showed a robust
nd significant induction of Arc mRNA levels in the PFC following
IS exposure. In striking contrast, ketanserin treatment prevented
he upregulation of Arc mRNA observed following CIS administra-
ion to MS animals (Figure 4B). The Kruskal-Wallis test revealed
hat postnatal ketanserin treatment to MS animals significantly
revented the aberrant pattern of CIS-evoked ArcmRNA expres-
f the immediate early gene Arc within the prefrontal cortex in response
tment paradigms (A, C). Pups from Ctl and MS groups were subjected in
ods and Materials. In situ hybridization and quantitative densitometric
refrontal cortex. Shown are representative autoradiograms of ArcmRNA
rom Ctl, MS, CIS, and MS CIS groups (D). Exposure to AIS in adulthood
in the prefrontal cortex (B). Ctl animals subjected to CIS in adulthood
trast, MS animals showed a significant induction of prefrontal ArcmRNA
nt of control and are the mean  SEM (n  3–5 per group). (*p  .05
tly different from CIS; analysis of variance and Bonferroni post hoc test).tion o
e trea
Meth
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imals
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perceion in the PFC (Figure 4B). We did not observe any influence of
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1028 BIOL PSYCHIATRY 2011;70:1024–1032 M. Benekareddy et al.postnatal ketanserin treatment on baseline Arc mRNA expres-
sion in the control groups.
Postnatal Ketanserin Treatment Prevents Specific
Transcriptional Changes Observed in the Prefrontal Cortex of
Maternally Separated Animals
MS animals exhibit a perturbed transcriptome in the PFC in adult-
hood, including alterations in genes associatedwith G-protein signal-
ing (proteinkinaseC:Prkcb1, pleckstrin:Plek, calcineurin:Ppp3ca, phos-
holipase C: Plcd4) and excitatory synapses (neuroligin 1: Nlgn1,
-methyl-D-aspartate receptor subunit 2D:Grin2d) (17).Weaddressed
Figure 4. Postnatal serotonin type 2 receptor blockade prevents the dys-
egulated pattern of expression of the immediate early gene Arcwithin the
refrontal cortex in response to adult-onset chronic immobilization stress
bserved in maternally separated animals. Shown is the experimental par-
digm (A) involving postnatal treatment with the serotonin type 2 recep-
or antagonist ketanserin (Ket) or vehicle (Veh) to rat pups from control
Ctl) or maternal separation (MS) groups followed by exposure in adult-
ood to sham or chronic immobilization stress (CIS) as described in
ethods and Materials. Shown are representative autoradiograms for
he vehicle-treated Ctl, MS, CIS, and MS  CIS groups, as well as the
etanserin-treated Ctl, MS, CIS, and MS  CIS groups (B). The robust
nduction of Arc messenger RNA (mRNA) levels in the prefrontal cortex
bserved in the vehicle-treated MS  CIS group was not observed in the
S CIS group that received postnatal Ket treatment. Postnatal Ket treat-
ment to Ctl animals did not alter ArcmRNA levels as comparedwith vehicle-
administered control animals. Results are expressed as percent of the con-
trol vehicle groupandare themeanSEM (n5–10pergroup). ($p .01
ignificantly different from MS, 
p  .05 significantly different from CIS;
nonparametric Kruskal-Wallis test and Dunn’s post hoc test). P, postnatal
day.hether postnatal ketanserin treatment would prevent the altered k
www.sobp.org/journalxpression of these specific genes perturbed in the PFC of adult MS
nimals (Table 1). Ketanserin treatment during MS prevented the in-
uctionofPrkcb1,Plek,andPpp3camRNAin thePFC(Table1).Two-way
NOVA analysis revealed a significantMS Ket interaction for Prkcb1
F (1,27)  9.46, p  .005], Plek [F (1,27)  11.63, p  .002], and
pp3ca [F (1,27) 17.35, p .0003] mRNA levels. In contrast, two-
ay ANOVA analysis indicated no significant MS Ket interaction
orPlcd4 [F (1,27)2.06,p .16],Nlgn1 [F (1,27)3.90,p .06], and
rin2d [F (1,27) 2.60, p .12]. Postnatal ketanserin treatment in
ontrol animals did not alter the baseline adult expression of
hese genes in the PFC. Taken together, our results indicate that
ostnatal ketanserin treatment prevents the altered regulation
f specific genes known to be perturbed in the adult PFC follow-
ng MS.
We next sought to examine whether postnatal treatment with
he 5-HT2 receptor antagonist ketanserin during MS influences the
rajectory of expression of 5-HT2A and 5-HT2C receptors within the
FC (Figure 5A–E). In situ hybridization revealed that 5-HT2A mRNA
evels are not regulated byMS at P10 in the IL, PL, or CC divisions of
he PFC (Figure 5B). At the end of the MS paradigm on P14, MS
nimals exhibited significantly enhanced 5-HT2A mRNA levels
pecifically within the PL subdivision of the PFC (Figure 5C).
nterestingly, postnatal ketanserin treatment prevented this MS-
ssociated induction in 5-HT2A mRNA levels [one-way ANOVA:
(1,11)  15.11, p  .0007]. In contrast, 5-HT2C receptor expres-
ion in the PFC was unaltered in MS animals at both the ages
xamined (Figure 5D, E).
iscussion
The early life stress of MS evokes several long-term conse-
uences, including increased adult anxiety behavior (7–9), per-
urbed stress responses (7,10,11), and transcriptional changes in
ey limbicneurocircuitry (17).We recently reported thatMSanimals
xhibit enhanced 5-HT2 receptor function and increased expres-
ion of genes linked to 5-HT2 receptor signaling in the PFC (17). The
ajor finding of the present study is that pharmacological block-
de of the 5-HT2 receptor in postnatal life prevents the emergence
f enhanced anxiety in MS animals. Postnatal ketanserin treatment
lso blocks the enhanced expression of 5-HT2A receptor mRNA
bserved in the PFC in postnatal life and prevents the upregulation
f specific genes linked to 5-HT2 receptor signaling (Prkcb1, Ppp3ca,
nd Plek) in the PFC of adult MS animals. Further, we show that MS
isrupts the pattern of IEG expression evoked by chronic stress in
dulthood, and postnatal 5-HT2 receptor blockade normalizes this
ysregulated pattern. Taken together, our findings demonstrate
hat postnatal treatment with the 5-HT2 receptor antagonist ketan-
erin prevents the emergence of specific sequelae of MS and impli-
ates 5-HT2 receptors in the establishment of affective dysfunction
n animals with a history of early stress.
Perturbations of serotonergic neurocircuitry in postnatal life
ave been strongly linked to the establishment of altered anxi-
ty states in adulthood (13,14,28). Pharmacological studies in-
olving postnatal treatment with serotonin selective reuptake
nhibitors result in persistent increases in adult anxiety behavior
29). Conditional genetic loss of function of the forebrain sero-
onin type 1A (5-HT1A) receptor restricted to postnatal life
vokes enhanced anxiety in adulthood (30). Further, postnatal
harmacologic blockade of the 5-HT1A receptor is associated
ith an increase in anxiety (31). In contrast to the anxiogenic
tate observed in the 5-HT1A receptor knockouts (30) or follow-
ng postnatal 5-HT receptor blockade (31), 5-HT receptor1A 2A
nockouts exhibit anxiolytic effects in adulthood (15). However,
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M. Benekareddy et al. BIOL PSYCHIATRY 2011;70:1024–1032 1029the consequences of 5-HT2 receptor perturbations in postnatal
ife on the emergence of anxiety behavior in adulthood have not
een examined. It is noteworthy that animals with a history of
S exhibit enhanced adult anxiety, accompanied by robust in-
reases in 5-HT2 receptor function that emerge soon following
MS and persist into adulthood (17). Further, we demonstrate
that during postnatal life MS animals exhibit a significant in-
crease in 5-HT2AmRNA levels within the prelimbic subdivision of
the PFC. Strikingly, we find that postnatal ketanserin treatment
blocks both the MS-evoked changes in prefrontal 5-HT2A mRNA
expression in postnatal life, as well as the emergence of anxiety
behavior following MS in adulthood. These results raise the pos-
sibility of a link between enhanced 5-HT2 responses and the
establishment of increased anxiety that arises from adverse early
experience. However, while interpreting these results, it is im-
portant to note that ketanserin, which has a high affinity and
selectivity for the 5-HT2 receptor over other serotonergic and
opaminergic receptors, does not show a strong selectivity for
he 5-HT2A over the 5-HT2C receptor subtype and is reported to
have a moderate affinity for the 1 adrenergic receptor (32).
While postnatal ketanserin treatment blocks anxiety behav-
ior in MS animals, it does not influence baseline anxiety in con-
trol animals, in striking contrast to studies demonstrating a ro-
bust effect on baseline adult anxiety following postnatal 5-HT1A
receptor (30) or serotonin transporter blockade (29). A possible
xplanation for why ketanserin treatment influences anxiety be-
avior only in MS animals and not in control animals may be
ecause MS is associated with elevated 5-HT2 receptor function
17). This suggests that the effects of postnatal ketanserin treat-
ent may predominantly modulate pathological anxiety states
hat arise as a consequence of early stress. The 5-HT2 receptor is
strong candidate for mediating stress-induced alterations in
ehavioral affect (33–36). 5-HT2 receptors are putative targets
or stand-alone (37,38) or adjunct antidepressant treatments
39,40). 5-HT2 receptor-mediated signaling is enhanced in pa-
tients with affective disorders (35) and in animal models of both
early life (17) and adult-onset chronic stress (41,42). Interest-
ingly, both early and adult stress evoke increases in prefrontal
5-HT receptor expression and function (17,43,44), suggesting
Table 1. Postnatal Treatment with Ketanserin Prevents
Separation in the Adult Prefrontal Cortex
Gene Ctl M
Prkcb1 1.00  .02 1.22 
Plek 1.00  .07 1.25 
Ppp3ca 1.00  .04 1.17 
Plcd4 1.00  .03 1.24 
Nlgn1 1.00  .09 1.30 
Grin2d 1.00  .05 1.28 
Animals from the control (Ctl) andmaternal separatio
with either the serotonin type 2 receptor antagonist keta
postnatal day 90. We examined the expression of gene
known to contribute to serotonin type 2 receptor-med
plasticity.Quantitativepolymerase chain reactionanalys
(Plek), calcineurin (Ppp3ca), phospholipase C (Plcd4), neu
2D (Grin2d) was performed from the prefrontal cortex as
transcripts was significantly induced in the prefrontal c
blocked themessenger RNA induction of Prkcb1, Ppp3ca
cortex. Data are expressed as fold change and are the m
Bonferroni post hoc test).
ap .05 compared with Ctl.
bp .01 significantly different fromMS.2A
hat independent of the timing of the stressor, a modulation of p-HT2 receptor function may serve to mediate the effects of
tressful life experiences in shaping individual differences in
ulnerability for adult psychopathology.
Adverse early life history is also known to evoke dysregulated
euroendocrine responses to adult stress (7,10,11) that have
een hypothesized to contribute to the exacerbated risk for
tress-related affective dysfunction. However, relatively little is
nown about the influence of early stress on the pattern of
entral circuit activation by adult stressors. Using IEG expression
o profile the pattern of neuronal circuit activation, adult stres-
ors show robust induction in Arc and c-fos mRNA in key limbic
eurocircuitry, including the PFC (25,45). The PFC plays an im-
ortant role in integrating the emotional salience of a stressful
timulus with eventual behavioral output (46–49). Strikingly,
he pattern of induction of IEGs in the PFC evoked by single
tress exposure habituates following repeated experience of the
ame stress (27). We provide novel evidence that a history of MS
esults in a failure to exhibit this habituation of Arc regulation in
he PFC following repeated stress in adulthood. This suggests
hat chronic stress may continue to be perceived as novel in
nimals with adverse early life experience or alternatively that
echanisms that regulate the habituation of prefrontal circuits
ollowing chronic stress may be dysfunctional in MS animals.
iven the top-down control of the PFC in modulating anxiety
50), altered prefrontal circuit activation in MS animals may have
significant effect on stress-evoked anxiety responses. It is inter-
sting to speculate that the perturbed stress sensitivity of pre-
rontal circuits in MS animals may then contribute to the predis-
osition for psychopathology, possibly by influencing the
refrontal control of key subcortical circuits including the
mygdala (51,52). We find that postnatal 5-HT2 receptor block-
de normalized the differential pattern of Arc expression in pre-
rontal cortical circuits evoked by chronic stressors in MS ani-
als. Taken together, our results demonstrate the ability of
ransient postnatal ketanserin treatment to prevent both en-
anced anxiety and the perturbed pattern of stress-induced IEG
esponse observed in MS animals. While largely speculative, this
pens up the possibility that enhanced 5-HT2 receptor function
n the PFC may contribute to both the increased anxiety and the
ific Transcriptional Changes Induced by Maternal
Ket MS Ket
1.04  .10 1.01  .13b
1.12  .08 1.03  .13b
1.06  .02 .99  .04b
.99  .13 1.07  .19
1.20  .09 1.22  .16
1.15  .15 1.29  .18a
) groups received treatment frompostnatal days 2 to14
n (Ket) or vehicle, and gene expressionwas examined at
specific interest implicated in G-protein signaling and
signal transduction, cellular excitability, and neuronal
he followinggenes, protein kinaseC (Prkcb1), pleckstrin
n 1(Nlgn1), and N-methyl-D aspartate-receptor subunit
ibed inMethods andMaterials. The expression of these
of MS animals in adulthood. Postnatal Ket treatment
Plek but not of Plcd4,Nlgn1, andGrin2d in the prefrontal
 SEM (n 5–10 per group). (Analysis of variance andSpec
S
.04a
.03a
.03a
.05a
.05a
.03a
n (MS
nseri
s of
iated
is for t
roligi
descr
ortex
, and
eanerturbed pattern of stress-induced prefrontal circuit activation.
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1030 BIOL PSYCHIATRY 2011;70:1024–1032 M. Benekareddy et al.Figure 5. Postnatal ketanserin (Ket) treatment prevents thematernal separation (MS)mediated induction of 5-HT2Amessenger RNA (mRNA) at postnatal day
4 (P14) in the prelimbic region of the prefrontal cortex (PFC). Shown is a schematic of the treatment paradigm (A). Pups from vehicle (Veh)-treated control
Ctl), Veh-treatedMS, and Ket-treatedmaternal separation (MS Ket) groupswere assessed for 5-HT2A (C, D) and 5-HT2C (E, F)mRNA expression at postnatal
day 10 (P10) and P14 in the infralimbic (IL), prelimbic (PL), and cingulate cortex (CC) subdivisions of the prefrontal cortex (B) using in situ hybridization.
Maternal separation animals exhibited a selective induction in 5-HT2A receptor mRNA levels in the PL subdivision of the PFC at P14 (D) and not P10 (C).
nterestingly, postnatal Ket treatment during MS prevented this MS-mediated increase in 5-HT2A mRNA levels. 5-HT2C receptor mRNA was found to be
naltered at both P10 and P14 in the PFC ofMS animals (E, F). Results are expressed as percent of the Ctl group and are themean SEM (n 3–6 per group).
* $p .05 significantlydifferent fromCtl, p .05 significantlydifferent fromMSKet; analysis of varianceandBonferroni post hoc test). 5-HT2A, serotonin type
2A; 5-HT2C, serotonin type 2C; P2, postnatal day 2. (Panel redrawn with permission from Paxinos and Watson [64], copyright Elsevier 1997.)
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M. Benekareddy et al. BIOL PSYCHIATRY 2011;70:1024–1032 1031While we have demonstrated that postnatal ketanserin treat-
ment blocks both anxiety and dysfunctional patterns of stress-
evoked IEG responses, at this juncture it is difficult to pinpoint
specific neuronal circuits that may be targeted by systemic ket-
anserin treatment to mediate its effects. We addressed whether
MS evokes a change in prefrontal expression of 5-HT2A and
5-HT2C receptors and whether MS-induced changes are influ-
nced by postnatal ketanserin treatment. MS animals showed a
elective induction of prelimbic 5-HT2A receptor mRNA levels at
14, an effect blocked in MS animals that received postnatal
etanserin treatment. Interestingly, MS animals in adulthood do
ot show any change in the mRNA levels of either 5-HT2A or
5-HT2C receptors (17), suggesting a relatively transient effect of
S on prefrontal 5-HT2A receptor expression. However, adult MS
nimals exhibit robustly enhanced 5-HT2A receptor function,
ikely through enhanced expression of downstream signaling
athways, including enhanced expression of genes such as pro-
ein kinase C—Prkcb1, calcineurin—Ppp3ca, and phospholipase
—Plcd4 (17). We also find that postnatal ketanserin treatment
prevents the enhanced expression of specific genes (Prkcb1,
Ppp3ca) implicated in altered 5-HT2A receptor signaling (53–55)
n the PFC of MS animals in adulthood. Increased protein kinase
function is implicated in the prefrontal dendritic spine loss and
orking memory deficits associated with chronic stress (56).
etanserin treatment, by preventing the enhanced expression of
alcineurin and Prkcb1, may serve to ameliorate the enhanced
ulnerability to chronic stress-evoked pathology and the in-
reased 5-HT2 receptor function inMS animals. We also observed
that ketanserin treatment did not block the disrupted regulation
of specific MS-evoked gene expression changes (Nlgn1, Grin2d,
Plcd4). One can envisage that the effects of ketanserin on behav-
ioral consequences of MS may arise mechanistically, either
through a prevention of underlyingmolecular events that estab-
lish perturbed anxiety or through the induction of adaptive
compensatory changes that counteract MS-evoked anxiety-in-
ducing molecular mechanisms.
Previous studies have predominantly focused on reversing in
adolescence or adulthood the adverse effects of MS on anxiety
behavior using both enriched environment (57) and chronic
antidepressant administration (8,58). However, relatively few
studies have involved interventions that overlap with the period
of MS and may serve to negate the emergence of adverse con-
sequences of early stress exposure. A single report indicates that
pharmacologic treatment with a neuroactive steroid, tetrahy-
drodeoxycorticosterone, during MS can block the behavioral
and neuroendocrine sequelae of early stress (59). Given the
trong interrelationship between neuroactive steroid pathways
nd 5-HT2 receptors (60–62), it is possible that these systems
ay play a critical role in postnatal life in mediating the conse-
uences of early stress. Evidence of a reciprocal relationship
etween 5-HT2 receptors and corticotrophin releasing factor
63) raises the possibility that these systems may also cross-
ensitize their responses to stress exposure.
In summary, our data clearly demonstrate that postnatal ketan-
erin treatment prevents the emergence of anxiety following MS,
nd alongwith prior results, strongly link perturbed 5-HT2 receptor
unction following MS to the establishment of susceptibility for
dult anxiety. Given the increasing need for early treatment inter-
entions that prevent the development of affective vulnerability,
ur results underscore the importance of 5-HT2 receptors as poten-
tial therapeutic targets.This research was supported by a Wellcome Trust Senior Overseasellowship (VAV;0408200314133)andaTata InstituteofFundamental
esearch Intramural Grant (VAV).
We acknowledge Ramya Ranganathan and Sapna N. Shetty for
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